Protagonist Therapeutics Inc (PTGX) — Cash Flow Quality Index

Latest as of December 2024: -0.22x

Protagonist Therapeutics Inc (PTGX) has a Cash Flow Quality Index of -0.22x as of December 2024. Operating cash flow of $-29.18 Million is below net income of $131.67 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Protagonist Therapeutics Inc (PTGX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.22x

Operating CF / Net Income

Operating Cash Flow

$-29.18 Million

USD

Net Income

$131.67 Million

USD

Data as of

Dec 2024

Most recent filing

Protagonist Therapeutics Inc Cash Flow Quality Index (2024–2024)

Historical Cash Flow Quality Index for Protagonist Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Protagonist Therapeutics Inc cash conversion from operations.

Annual Cash Flow Quality Index for Protagonist Therapeutics Inc (2024–2024)

Year-by-year earnings quality comparison for Protagonist Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change
2024	0.67x	$184.15 Million	$275.19 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.